India and Britain’s new corona strains also affect Bharat Biotech’s COVAXIN

India and Britain's new corona strains also affect Bharat Biotech's COVAXIN

New variants of the virus remain a concern in the second wave of the Corona epidemic. Meanwhile, on behalf of Bharat Biotech, it has been said that their native Corona vaccine Kovaxin is available on all new Corona variants. Is effective, It also includes new variants found in India, UK etc.

It also includes B.1.617 and B.1.1.7 Corona variants which were found in India and the United Kingdom. Bharat Biotech said this about the vaccine on Sunday (May 16, 2021). From India Biotech Been told There has been no change in neutrification of B.1.1.7 (previously found in the UK) and vaccine strains (D614G) on the use of the vaccine. Bharat Biotech has done this latest study in collaboration with National Institute of Virology and India Council of Medical Research.

Vaccine is effective on all strains

This study was carried out inside the lab towards ICMR. The study found that there was no difference in neutralization between the UK variant and the vaccine strain after the vaccine. The special thing is that the Oxford’s Covishield vaccine is also including Britain Effective on all variants Has been However, its impact on the strains of South Africa has been less visible. But the special thing is that the Africans Strain Cases have not been seen in India.

Earlier, scientists from the Indian Council of Medical Research (ICMR) reported in their preliminary reports of the research that the Indian vaccine is producing only a few antibodies against the B1.617 variant of covichelid and covaxine corona virus, but this vaccine Are effective over other variants of the Corona.

The B.1.617 variant of the corona virus was first detected in Maharashtra. Scientists from the ICMR and the National Institute of Virology (NIV) were collecting samples of corona-positive patients. They then tested these samples on different variants of Corona virus from January to now, B.1.1.7 (UK), B.1.351 (South Africa), P 2 variant (Brazil) and B.1.617 variants. Currently, the B.1.617 variant in India seems to be growing in large numbers.

Two corona vaccines are being used in India, Sputnik also consigned

Covacine is one of the three vaccines that have been approved for use in India. Apart from this, Kovmshield of Sirum Institute and Sputnik Corona vaccine of Russia are being used in India. So far more than 18 crore (18,22,20,164) Corona vaccines have been applied in the country. Corona vaccination of people from 18 years to 44 years started in the country from 1 May. Earlier people above the age of 45 were being given the Corona vaccine.